Figure 1
Figure 1. DDR2 is expressed and functional in human primary neutrophils. (A) DDR2 is phosphorylated upon activation by collagen I. Human primary neutrophils were cultured in the presence of collagen I (pretreated with or without rDDR). DDR2 was immunoprecipitated from cell lysates at different times of collagen treatment. Results are representative of 3 independent experiments. (B) DDR2 phosphorylation is inhibited by DDR2 blocking-antibodies. Human primary neutrophils were pretreated for 30 minutes with blocking DDR2 antibodies (50 μg/mL) and cultured in collagen I for 1 hour. DDR2 was immunoprecipitated from cell lysates. Results are representative of 3 independent experiments. (C) MMP secretion is amplified after DDR2 activation. Human primary neutrophils were embedded in collagen I (treated with or without rDDR) and stimulated with 500nM IL-8. The supernatant was collected and added to a solution of DQ collagen. The fluorescence generated by collagen hydrolysis was measured at 515 nm. The pan-MMP inhibitor GM6001 (25μM) was used as control. Results represent the data from 4 independent experiments. *P < .05; Friedman test; Dunn posthoc test. (D) MMP-8, but not MMP-9, secretion is amplified on DDR2 activation. Human primary neutrophils were embedded in collagen and stimulated with 500nM IL-8. DDR2 activity was inhibited either by collagen pretreatment with rDDR or with blocking DDR2 antibodies (pretreatment for 30 minutes). The levels or MMP-8 and MMP-9 in the supernatant were determined by ELISA. Results represent the data from 3 independent experiments. *P < .05; Friedman test; Dunn posthoc test.

DDR2 is expressed and functional in human primary neutrophils. (A) DDR2 is phosphorylated upon activation by collagen I. Human primary neutrophils were cultured in the presence of collagen I (pretreated with or without rDDR). DDR2 was immunoprecipitated from cell lysates at different times of collagen treatment. Results are representative of 3 independent experiments. (B) DDR2 phosphorylation is inhibited by DDR2 blocking-antibodies. Human primary neutrophils were pretreated for 30 minutes with blocking DDR2 antibodies (50 μg/mL) and cultured in collagen I for 1 hour. DDR2 was immunoprecipitated from cell lysates. Results are representative of 3 independent experiments. (C) MMP secretion is amplified after DDR2 activation. Human primary neutrophils were embedded in collagen I (treated with or without rDDR) and stimulated with 500nM IL-8. The supernatant was collected and added to a solution of DQ collagen. The fluorescence generated by collagen hydrolysis was measured at 515 nm. The pan-MMP inhibitor GM6001 (25μM) was used as control. Results represent the data from 4 independent experiments. *P < .05; Friedman test; Dunn posthoc test. (D) MMP-8, but not MMP-9, secretion is amplified on DDR2 activation. Human primary neutrophils were embedded in collagen and stimulated with 500nM IL-8. DDR2 activity was inhibited either by collagen pretreatment with rDDR or with blocking DDR2 antibodies (pretreatment for 30 minutes). The levels or MMP-8 and MMP-9 in the supernatant were determined by ELISA. Results represent the data from 3 independent experiments. *P < .05; Friedman test; Dunn posthoc test.

Close Modal

or Create an Account

Close Modal
Close Modal